1.      ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology. J Am Coll Cardiol. 2014;64:2039-60.

2.      Adeyinka A, Kondamudi NP. Cyanosis. StatPearls Publishing. 2023.

3.      Anderson JB, Willis M, Lancaster H, et al. The Evaluation and Management of Pediatric Syncope. Pediatr Neurol. 2016;55:6-13.

4.      Anderson JB, Willis M, Lancaster H, Leonard K, Thomas C. The evaluation and management of pediatric syncope. Pediatr Neurol. 2016;55:6-13.

5.      Arrhythmias in Pediatrics: How To Diagnose and Treat Young Patients. GE HealthCare. 2022.

6.      Artificial Intelligence in Pediatric Cardiology: A Scoping Review. Front Pediatr. 2021;9:675721.

7.      Atmanli A, Yen K, Zhou AZ. Diagnostic testing for chest pain in a pediatric emergency department and rates of cardiac disease before and during the COVID-19 pandemic: a retrospective study. Front Pediatr. 2024;12:1366953.

8.      Attenhofer Jost CH, Connolly HM, Dearani JA, et al. Ebstein's anomaly. Circulation. 2007;115:277-85.

9.      Batra AS, Silka MJ, Borquez A, et al. Pharmacological management of cardiac arrhythmias in the fetal and neonatal periods: a scientific statement from the American Heart Association. Circulation. 2024;149:e937-e952.

10.  Brancato F, De Rosa G, Gambacorta A, et al. Role of troponin determination to diagnose chest pain in the pediatric emergency department. Pediatr Emerg Care. 2021;37:e1589-e1592.

11.  Brothers JA, Frommelt MA, Jaquiss RD, et al. Expert consensus guidelines: Anomalous aortic origin of a coronary artery. J Thorac Cardiovasc Surg. 2017;153:1440-57.

12.  Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. EP Europace. 2013;15:1337-82.

13.  Chest Pain in Children and Adolescents. Pediatr Ann. 2025;54:e57-e63.

14.  Common cardiovascular problems in the young: Part I. Murmurs, chest pain, syncope and irregular rhythms. Am Fam Physician. 1997;56:1825-30.

15.  Craig TK, Cox AD, Klein K. Intergenerational Transmission of Somatisation Behaviour: A Study of Chronic Somatizers and Their Children. Psychol Med. 2002;32:805-16.

16.  Crosson JE, Callans DJ, Bradley DJ, et al. Emergency diagnosis and management of pediatric arrhythmias. J Emerg Trauma Shock. 2010;3:251-8.

17.  Cyanosis. Cincinnati Children's Hospital Medical Center. 2024.

18.  Deal BJ, Keane JF, Gillette PC, Garson A Jr. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol. 1985;5:130-5.

19.  Fogliazza F, Cifaldi M, Antoniol G, et al. Approaches to Pediatric Chest Pain: A Narrative Review. J Clin Med. 2024;13:6659.

20.  Genomics and Precision Medicine in Pediatric Cardiology. Circ Genom Precis Med. 2024;17:e004156.

21.  Hiremath G, Kamat D. Diagnostic considerations in infants and children with cyanosis. Pediatr Ann. 2015;44:76-80.

22.  Huang SW, Liu YK. Pediatric Chest Pain: A Review of Diagnostic Tools in the Pediatric Emergency Department. Diagnostics. 2024;14:526.

23.  Hughes T. Cyanosis. Pediatric Care Online. American Academy of Pediatrics. 2024.

24.  Kafali HC, Ergul Y. Common Supraventricular and Ventricular Arrhythmias in Children. Turk Arch Pediatrics. 2022;57:476-488.

25.  Kilinc F, Karakurt C, Elkiran O, Ince D. Myocarditis in Childhood Report of 67 Patients. Ann Med Res. 2022;29:1024-8.

26.  Leung AK, Robson WL, Cho H. Chest pain in children. Can Fam Physician. 1996;42:1156-60.

27.  Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease. Circulation. 2009;120:447-58.

28.  Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-92.

29.  Martin GR, Beekman RH, Mikula EB, et al. Implementing recommended screening for critical congenital heart disease. Pediatrics. 2013;132:e185-92.

30.  Martin GR, Ewer AK, Gaviglio A, et al. Updated strategies for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2020;146:e20191650.

31.  McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:15071.

32.  Norwood WI, Lang P, Hansen DD. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med. 1983;308:23-6.

33.  Oster ME, Aucott SW, Glidewell J, et al. Lessons learned from newborn screening for critical congenital heart defects. Pediatrics. 2016;137:e20154573.

34.  Pahal P, Goyal A. Central and Peripheral Cyanosis. StatPearls Publishing. 2022.

35.  Perez-Lugones A, Schweikert R, Pavia S, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol. 2001;12:935-938.

36.  Perez-Lugones A, Schweikert R, Pavia S, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope. J Cardiovasc Electrophysiol. 2001;12:935-8.

37.  Raj SR, Rose S, Ritchie D, Sheldon RS. The Second Prevention of Syncope Trial (POST II): a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope. Am Heart J. 2006;151:1186.

38.  Ramachandra R, Ellison GA, Su F, Punn R. Reversed differential cyanosis in the newborn: a clinical finding in the supracardiac total anomalous pulmonary venous connection. CASE (Phila). 2024;8:21-24.

39.  Rodday AM, Triedman JK, Alexander ME, et al. Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Pediatrics. 2012;129:e999-e1010.

40.  Rudolph AM. The changes in the circulation after birth. Their importance in congenital heart disease. Circulation. 1970;41:343-59.

41.  Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol. 2005;45:484-488.

42.  Sasidharan P. An approach to diagnosis and management of cyanosis and tachypnea in term infants. Pediatr Clin North Am. 2004;51:999-1021.

43.  Scott WA, Pongiglione G, Bromberg BI, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol. 1995;76:400-402.

44.  Shaddy RE, Snider AR, Silverman NH, Lutin WA. Pulsed Doppler findings in patients with coarctation of the aorta. Circulation. 1986;73(1):82–88. DOI: 10.1161/01.CIR.73.1.82..

45.  Treating Arrhythmias in Children. American Heart Association. 2024.

46.  van Dijk JG, van Rossum IA, Thijs RD. Timing of circulatory changes during typical vasovagal syncope. JACC Clin Electrophysiol. 2020;6:1667-1676.

47.  van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope. J Am Coll Cardiol. 2006;48:1652-7.

48.  Wang C, Liao Y, Wang S, et al. Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (revised 2024). World J Pediatr. 2024;20:983-1002.

49.  Wearable Technology in Pediatric Cardiology: Current Applications and Future Directions. Pediatr Cardiol. 2023;44:1245-58.

50.  Yücel İK, Çevik A, Bulut MO, Dedeoğlu R, Demir İH, Erdem A, Çelebi A. Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease. Cardiol Young. 2015 Jan;25(1):56-62. doi: 10.1017/S1047951113001522.